Iris Pharma, a French contract research organization (CRO) has an alliance with the Institut de la Vision, a research center dedicated to eye diseases. “Iris Pharma found it natural to become involved in a project of such scope and so promising in terms of research and advances in eye diseases. It was natural for our company, a specialist in preclinical studies and clinical trials in ophthalmology, to become one of the Institut de la Vision’s preferred partners,” said Pierre-Paul Elena, CEO and founder of Iris Pharma. Here’s the release.

Canada’s Algorithme Pharma, a Phase I CRO, has bought the clinical pharmacology research office of Bioanalytical Systems. The acquired Baltimore clinic includes a 46,000 square-foot work space with 120 beds, divided into three separate research units. The division will now be known as Algorithme Pharma USA. “This acquisition is the first step in our U.S. expansion strategy and is part of a vast development plan to pursue our organic growth in Canada and take advantage of business opportunities that will enable us to diversify on the international scene, in both the U.S. and Europe,” said Louis Caillé, president and CEO of Algorithme Pharma.

ACR Image Metrix, a CRO, is pleased to announce the addition of Yi Zhu to its clinical research staff as clinical research project manager. Ms. Zhu is responsible for developing and reviewing all clinical study documentation, as well as managing site selection and coordination. “We are pleased to have Yi join our staff. She will be based in Philadelphia and brings an immense amount of experience as a clinical research manager to Image Metrix,” said Mike Morales, VP and general manager, ACR Image Metrix. Here’s the release.

Piyush Patel of Cetero Research, a CRO, is finalists of Ernst & Young’s Ontario Entrepreneur of the Year Award for 2008. “We have seen extraordinary entrepreneurial spirit here in the 15 years since establishing the program in Canada. Time and time again, individuals find exciting new ways of doing business and meeting market needs,” said Dan Cornacchia, national and Ontario director of the Entrepreneur Of The Year Awards program. Here’s the release.

The market for clinical trials in Poland may stall if red tape in the former Communist country isn’t removed. That’s the view from this article.

Clinical technology suite ClinPhone and Cytel, a biostatistical software and consulting firm, announced a marketing alliance. Their integrated service will provide all the components for adaptive trial planning and implementation, including study design consulting, trial simulations, supplies planning and management, clinical data collection, randomization, trial supply management, data analysis and reporting. Irving Dark, Cytel’s VP of clinical research services says: “The ClinPhone-Cytel collaboration provides sponsors with the full-service offering needed for successful adaptive clinical trials. This partnership underscores our commitment to be the leader in innovative trial design and implementation services.”

Have a news release? Send it to .(JavaScript must be enabled to view this email address).